Iron Deficiency Anemia in Adults

Author

Zeynep Agit

Marmara University, Faculty of Pharmacy

Author

Dr. Abdullah Agit

Istanbul Bahçelievler Medical Park Hospital, Department of Hematology

"Anemia is a late finding due to iron deficiency."

What is anemia?

Anemia is a condition in which erythrocyte (red blood cell) mass and hemoglobin (Hb) levels are below Hb <12 g/dL in women and Hb <13 g/dL in men. Anemia is a laboratory finding and the cause is important. Iron deficiency anemia (IDA) is the most common cause of anemia [1]. Anemia is a late finding due to iron deficiency. Anemia begins to develop after iron stores in the bone marrow are depleted

Causes and risk factors of iron deficiency anemia

When we look at the causes of iron deficiency anemia, we can count three main causes; inadequate intake of iron from food, conditions with iron malabsorption (imperfect absorption), and iron loss more than iron intake.

In adults in developed countries, dietary intake is usually adequate and it is important to assume that the cause is blood loss until proven otherwise and to investigate this as a priority. However, this is not the case for underprivileged populations. As in the diagnosis of many diseases, a good history is the most important factor in determining the cause of iron deficiency anemia. Nutritional status, the presence of diarrhea in terms of possible malabsorption, previous gastrointestinal surgery, medications, and the presence of any bleeding foci should be questioned in detail.

Reduced iron absorption

Iron is absorbed in the upper gastrointestinal tract, with the duodenum being the site of highest absorption [3]. Reduced iron absorption is a rare cause of iron deficiency, especially in healthy individuals and in parts of the world where there is access to an iron-rich diet.

Disorders affecting mucosal cells responsible for iron absorption such as celiac disease, atrophic (autoimmune*) gastritis, Helicobacter pylori infection, and bariatric surgery (surgery for obesity that cannot be treated with diet and exercise) are important causes of malabsorption (imperfect absorption).

In people with gastrointestinal symptoms or inadequate response to oral iron supplementation, sources of reduced iron absorption may be considered. A source of bleeding should be excluded, whether or not reduced iron absorption has been documented.

*Autoimmune: A situation in which a person creates an immune response against his or her own cells and tissues as a result of a disorder in the immune system.

Dietary

Heme iron (iron from meat rather than plant sources) is better absorbed than non-heme iron, but both sources are important. A review of published studies assessing vegetarians and non-vegetarians found that those who consumed a vegetarian diet were more likely to develop iron deficiency [4].

Some foods can impair iron absorption, such as tannins (found in tea), phosphates, phytates (mineral-binding compounds found in whole grains and seeds), and foods high in calcium

One case report described iron deficiency in an individual who drank excessive amounts of tea (more than 1500 mL per day for 20 years). Upper and lower endoscopies showed no pathological conditions and hemoglobin increased with cessation of tea drinking and decreased with continued tea drinking [5].

Celiac disease (gluten-sensitive enteropathy)

Celiac disease (gluten-sensitive enteropathy) is a small intestinal malabsorption disorder triggered by exposure to gluten in susceptible individuals. Iron may contribute to anemia through several mechanisms, including malabsorption (imperfect absorption) of other nutrients required for red blood cell (RBC) production, including vitamin B12, folic acid, and copper [6].

Autoimmune gastritis or Helicobacter pylori

Autoimmune gastritis or Helicobacter pylori (H. pylori); gastritis due to an autoimmune mechanism (e.g., anti-parietal cell antibodies) or H. pylori has also been shown to be an important cause of iron deficiency [7,8].

Bariatric surgery

Iron requires to be conjugated with vitamin C, amino acids, or sugars in the presence of gastric acid to protect it from alkaline (in a base pH) secretions in the proximal jejunum; otherwise, iron is converted to ferric hydroxide and cannot be absorbed. Bariatric surgery involves a number of procedures that promote weight loss by limiting the reservoir capacity of the stomach and/or shortening the length of the functional small intestine, leading to malabsorption (imperfect absorption). The risk of causing iron deficiency is highest as it reduces the absorption area. Monitoring iron status is recommended after most bariatric surgeries with routine iron supplementation or iron supplementation as needed.

Drugs

An acidic gastric environment facilitates the absorption of iron, especially non-heme iron. Reduced gastric acidity alone is unlikely to cause clinically significant iron deficiency in an individual with adequate dietary iron intake and a normally functioning gastrointestinal tract.

Drugs that reduce gastric acidity, especially proton pump inhibitors (PPIs, stomach protector), have been suggested to decrease iron absorption [9,10].

Inherited disorders that interfere with iron absorption

Inherited disorders that interfere with iron absorption are very rare. IRIDA (iron therapy-resistant iron deficiency anemia) due to a TMPRSS6 mutation is a rare inherited disorder in which oral iron absorption is markedly impaired. IRIDA is caused by loss-of-function mutations of the TMPRSS6/matriptase 2 gene, which encodes a serine protease that cleaves membrane-bound hemojuvelin [11,20]. It causes iron deficiency due to inappropriately high levels of hepcidin, markedly decreased iron absorption, and increased iron uptake in macrophages* [17, 21-26]. Patients present with mild hypochromic*, microcytic anemia*** with very low serum iron levels and low transferrin saturation. Serum ferritin levels are usually in the normal range or slightly elevated following intravenous iron therapy [17].

*Macrophage: These are white blood cells that protect the body against diseases.

**Hypochromia: The amount of hemoglobin in the red blood cell is below the reference range of 32 - 36 grams/deciliter (g/dL).

***Microcytic anemia: It suggests a type of anemia in which red blood cells are smaller than normal.

Iron deficiency anemia due to iron loss

Menstrual bleeding is the most important cause of iron deficiency anemia in premenopausal women. Gastrointestinal bleeding in postmenopausal women and adult men is an important cause of IDA. Further investigations are absolutely necessary. Upper and lower gastrointestinal endoscopy is recommended to rule out the bleeding focus and possible malignancy (types of tumors that can be considered cancer). Bleeding disorders such as Von Willebrand Disease should also be kept in mind, especially in prolonged menstrual bleeding.

Symptoms of anemia

The usual symptoms in adults with iron deficiency are primarily due to anemia. The same symptoms may be present in non-anemic individuals with severely reduced iron stores and extremely low serum ferritin [27]. Weakness, fatigue, exhaustion, headache, rapid fatigue, palpitations, shortness of breath during exercise, and rapid chills are expected symptoms depending on the level of anemia.

Pica refers to the desire or compulsion to eat substances that are unsuitable as food and is an expected symptom in IDA.

These may include earth materials such as clay or dirt, paper products, corn starch, raw rice or pasta, ice, chalk, ash, and charcoal. The specific substances desired may depend on what is available and what is culturally acceptable [28,29].

Cravings for these non-food items can be intense. Pica is a symptom of iron deficiency, which is particularly common during pregnancy.

Restless legs syndrome (RLS) is a disorder in which there is an unpleasant or uncomfortable urge to move the legs during periods of inactivity. The discomfort is often immediately relieved by movement. RLS is common in the general population and in some series affects 5 to 15 percent of adults, particularly in the white population. Iron deficiency may be one of the most common causes of RLS, and RLS may be one of the more common clinical manifestations of iron deficiency.

Mood changes, and other possible causes should be investigated separately, but IDA should also be kept in mind.

Symptoms of anemia

In individuals with iron deficiency (with or without anemia), physical examination may be normal or may reveal one or more of the following findings [27,30]; pale skin, dry or rough skin, atrophic (the structure becomes smaller) glossitis (tongue inflammation) with loss of tongue papillae that may be accompanied by tongue pain or dry mouth, cheilosis (cracks in the corners of the mouth), spoon nails, esophageal web that may be accompanied by dysphagia, hair loss

Treatment

The most important step is to find out the cause of IDA. It is important to eliminate the bleeding focus, if any, or to organize the treatment of malabsorption (imperfect absorption), if there is a malabsorption picture, for a permanent treatment process.

When treatment is needed, the general approach is iron supplementation. Unless patients have severe anemia with hemodynamic instability, blood transfusion should not be used to treat iron deficiency. Oral replacement therapy should be the first choice unless the patient has oral malabsorption or complains of significant gastrointestinal side effects. Oral iron therapy can be given as ferrous sulfate, ferrous fumarate, and ferrous gluconate. The daily dose of iron to be taken in adults is 180 mg of elemental iron.

Intravenous (i.v.) iron therapy should be planned in patients who cannot tolerate oral iron therapy, those with severe anemia, high iron loss, iron malabsorption, hemodialysis patients, and some special cases in pregnancy and cancer cases. Iron sucrose, iron gluconate, iron dextran, and iron carboxymaltose are iron preparations used intravenously.

1. Ferhanoğlu B. PDQ Hematoloji (William F.Kern, MD). 1. Baskı, İstanbul Medikal Yayıncılık, 2005: 1-155

2. Ünal S. Cecil Texbook of Medicine (L. Goldman, D. Ausiello). 22. Baskı. Güneş Yayınevi, 2006:963-75

3. Schröder O, Mickisch O, Seidler U, ve diğerleri. İnflamatuar barsak hastalığı olan hastalarda demir eksikliği anemisinin tedavisinde intravenöz demir sükroza karşı oral demir takviyesi - randomize, kontrollü, açık etiketli, çok merkezli bir çalışma. Am J Gastroenterol 2005; 100:2503.

4. Gasche C, Berstad A, Befrits R, ve diğerleri. İnflamatuar barsak hastalıklarında demir eksikliği ve aneminin tanı ve tedavisine ilişkin kılavuzlar. Inflamm Bowel Dis 2007; 13:1545.

5. Reinisch W, Chowers Y, Danese S, ve diğerleri. İnflamatuar barsak hastalığında demir eksikliğinin yönetimi – RAND/UCLA uygunluk yöntemiyle geliştirilen çevrimiçi bir araç. Aliment Pharmacol Ther 2013; 38:1109.

6. Gasche C, Evstatiev R, Haas T, ve diğerleri. İnflamatuar barsak hastalıklarında demir eksikliği ve aneminin tanı ve tedavisi. Avusturya IBD Çalışma Grubunun Mutabakatı]. Z Gastroenterol 2011; 49:627.

7. Mamula P, Piccoli DA, Peck SN, ve diğerleri. İnflamatuar barsak hastalığı olan çocuklarda demir eksikliği anemisi için toplam doz intravenöz demir dekstran infüzyonu. J Pediatr Gastroenterol Nutr 2002; 34:286.

8. Lindgren S, Wikman O, Befrits R, ve diğerleri. İBH hastalarında aneminin düzeltilmesi ve demir depolarının yenilenmesi açısından intravenöz demir sükroz, oral demir sülfattan daha üstündür: Randomize, kontrollü, değerlendiriciden kör, çok merkezli bir çalışma. Scand J Gastroenterol 2009; 44:838.

9. Kim YW, Bae JM, Park YK ve diğerleri. Gastrektomi Sonrası Akut İzovolemik Anemili Hastalarda İntravenöz Ferrik Karboksimaltozun Hemoglobin Yanıtı Üzerine Etkisi: FAIRY Randomize Klinik Çalışması. JAMA 2017; 317:2097.

10. Auerbach M, Achebe MM, Thomsen LL, Derman RJ. Bariatrik cerrahi sonrası demir eksikliği anemisi olan hastalarda demir sükroz (IS) ile karşılaştırıldığında ferrik derozomaltozun (FDI) etkinliği ve güvenliği. Obes Cerrahisi 2022; 32:810.

11. Khalafallah AA, Yan C, Al-Badri R, ve diğerleri. Postoperatif anemi tedavisinde intravenöz ferrik karboksimaltoza karşı standart bakım: prospektif, açık etiketli, randomize kontrollü bir çalışma. Lancet Haematol 2016; 3:e415.

12. Hershko C, Ronson A. Demir eksikliği, Helicobacter enfeksiyonu ve gastrit. Acta Haematol 2009; 122:97.

13. Auerbach M, Liang AS, Glaspy J. Kemoterapide ve kansere bağlı anemide intravenöz demir. Topluluk Oncol 2012; 9:289.

14. Gafter-Gvili A, Rozen-Zvi B, Vidal L, ve diğerleri. Kemoterapinin neden olduğu aneminin tedavisi için intravenöz demir takviyesi - randomize kontrollü çalışmaların sistematik incelemesi ve meta-analizi. Acta Oncol 2013; 52:18.

15. Rodgers GM 3rd, Becker PS, Blinder M, ve diğerleri. Kanser ve kemoterapinin neden olduğu anemi. J Natl Compr Canc Netw 2012; 10:628.

16. Kim YT, Kim SW, Yoon BS ve diğerleri. Eş zamanlı kemoradyoterapi ile tedavi edilen serviks kanseri hastalarında intravenöz olarak uygulanan demir sükrozun aneminin önlenmesine etkisi. Gynecol Oncol 2007; 105:199.

17. Dangsuwan P, Manchana T. Kemoterapi alan jinekolojik kanser hastalarında intravenöz demir ile kan transfüzyonunun azaltılması. Gynecol Oncol 2010; 116:522.

18. Steinmetz T, Tschechne B, Harlin O, ve diğerleri. Kanser ve kemoterapiye bağlı anemi tedavisinde ferrik karboksimaltoz ile klinik deneyim. Ann Oncol 2013; 24:475.

19. Spivak JL. Polisitemi vera: mitler, mekanizmalar ve yönetim. Kan 2002; 100:4272.

20. Clénin G, Cordes M, Huber A, ve diğerleri. Sporda demir eksikliği - tanımı, performans ve tedaviye etkisi. İsviçre Med Haftalık 2015; 145:w14196.

21. Alaunyte I, Stojceska V, Plunkett A. Iron ve kadın sporcu: demir durumunu ve egzersiz performansını iyileştirmeye yönelik diyet tedavisi yöntemlerinin gözden geçirilmesi. J Int Soc Spor Nutr 2015; 12:38.

22. Tolkien Z, Stecher L, Mander AP ve diğerleri. Demir sülfat takviyesi yetişkinlerde önemli gastrointestinal yan etkilere neden olur: sistematik bir inceleme ve meta-analiz. PLoS One 2015; 10:e0117383.

23. Bregman DB, Morris D, Koch TA, ve diğerleri. Hepsidin düzeyleri, demir eksikliği anemisi olan hastalarda oral demir tedavisine yanıtsızlığı öngörmektedir. Am J Hematol 2013; 88:97.

24. Werner E, Kaltwasser JP, Ihm P. [Ağızdan demir tedavisi: bağırsak emilimi ve bir yemeğin etkisi (yazarın çevirisi)]. Dtsch Med Wochenschr 1977; 102:1061.

25. Bazeley JW, Wish JB. KBH Anemisinde Demir Eksikliği için Yeni ve Gelişen Tedaviler: Bir Gözden Geçirme. Am J Böbrek Dis 2022; 79:868.

26. Powers JM, Buchanan GR, Adix L, ve diğerleri. Beslenmeyle İlgili Demir Eksikliği Anemisi Olan Küçük Çocuklarda Düşük Doz Demir Sülfat ve Demir Polisakkarit Kompleksinin Hemoglobin Konsantrasyonu Üzerine Etkisi: Randomize Bir Klinik Çalışma. JAMA 2017; 317:2297.

27. Lee T, Clavel T, Smirnov K, ve diğerleri. Oral ve intravenöz demir replasman tedavisi, İBH hastalarında bağırsak mikrobiyotasını ve metabolomunu belirgin şekilde değiştirir. Gut 2017; 66:863.

28. Cook JD, Reddy MB. Askorbik asit alımının tam bir diyetten hem içermeyen demir emilimine etkisi. Am J Clin Nutr 2001; 73:93.

29. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, ve diğerleri. Farklı oral demir takviyelerinin tolere edilebilirliği: sistematik bir inceleme. Curr Med Res Görüşü 2013; 29:291.

30. Macdougall IC, Strauss WE, McLaughlin J, ve diğerleri. KBH'li hastalarda demir eksikliği anemisinin tedavisinde ferumoksitol ve demir sükrozun randomize bir karşılaştırması. Clin J Am Soc Nephrol 2014; 9:705.7.